Zhaoke Ophthalmology Ltd
HKEX:6622

Watchlist Manager
Zhaoke Ophthalmology Ltd Logo
Zhaoke Ophthalmology Ltd
HKEX:6622
Watchlist
Price: 1.71 HKD 4.27% Market Closed
Market Cap: 933.9m HKD

P/E
Price to Earnings

-3.6
Current
-3.5
Median
20.5
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-3.6
=
Market Cap
933.9m HKD
/
Net Income
-237.5m CNY
Earnings Growth PEG
CN
Zhaoke Ophthalmology Ltd
HKEX:6622
Average P/E: 24.4
Negative Multiple: -3.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
63.7
49%
1.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
16.4
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
19.2
18%
1.1
CH
Roche Holding AG
SIX:ROG
24.8
32%
0.8
CH
Novartis AG
SIX:NOVN
16.4
17%
1
UK
AstraZeneca PLC
LSE:AZN
27
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.1
18%
0.6
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -56 N/A N/A
US
Pfizer Inc
NYSE:PFE
16.5
29%
0.6

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-1.7
2-Years Forward
P/E
-4.8
3-Years Forward
P/E
N/A